Loading provider…
Loading provider…
Hematology & Oncology Physician in Santa Monica, CA
NPI: 1538181110Primary Employer
UCLA Medical Plaza
uclahealth.org
HQ Phone
Get MD Frederic's Phone Numberphone_androidMobile
Get MD Frederic's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1990 - 2027

American Board of Internal Medicine
Internal Medicine
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
Fellowship • Hematology and Medical Oncology
1987 - 1990
Yale-New Haven Medical Center
Residency • Internal Medicine
Until 1987
Internship • Internal Medicine
1984 - 1985
Tufts University School Of Medicine
medicine.tufts.edu
Medical School
Until 1984
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 171 | 406 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 123 | 431 |
| 3 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 96 | 305 |
| 4 | 36415Insertion of needle into vein for collection of blood sample | 83 | 226 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 46 | 195 |
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects wi...
Authors: Sara A. Hurvitz, Linda D. Bosserman, David Chan, Christopher T Hagenstad, Frederick C Kass
Authors: Lynch, T J, Kalish, L A, Kass, F, Strauss, G, Elias, A, Skarin, A, Shulman, L, Sugarbaker, D, Frei, E
Journal: Cancer
Lead Sponsor: Translational Oncology Research International
Collaborators: National Cancer Institute (NCI), University of California, Los Angeles
Intervention / Treatment: OTHER: laboratory biomarker analysis, DRUG: everolimus
Lead Sponsor: Translational Oncology Research International
Collaborators: National Cancer Institute (NCI), University of California, Los Angeles
Intervention / Treatment: DRUG: carboplatin, BIOLOGICAL: trastuzumab, DRUG: docetaxel, DRUG: lapatinib ditosylate
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Trastuzumab, RADIATION: Whole Breast Irradiation